Author name: Leonardo Arias

The approval comes two months after Edwards Lifesciences scuttled plans to buy JenaValve for $945 million amid opposition from the Federal Trade Commission.

Constructing the cGMP facility will increase availability of actinium-225, a nuclear material central to radiopharmaceutical programs at AstraZeneca, Bristol Myers Squibb, Eli Lilly and Novartis.

BioSpace’s 2026 U.S. Life Sciences Salary Report delivers a comprehensive look at how salaries, bonuses and benefits evolved over the past year amid ongoing economic pressure and workforce re-calibration. It uncovers not just what people are earning, but how they’re thinking about compensation, career moves and total rewards in 2026.

Other MA plans are downsizing, upset about coding changes and lobbying for higher rates. Alignment is growing and unbothered by the policy and payment fuss. CEO John Kao lays out how his company is breaking away from the pack.

The acquisition, announced Tuesday, would expand Sutter outside its home state of California and into the Midwest. The nonprofits expect the deal to close by the end of the year.

En Chile, el formato móvil tiene una gran demanda. Aquí se están desarrollando activamente las redes móviles, los usuarios están acostumbrados a resolver sus tareas cotidianas a través del teléfono y el deporte ocupa un lugar importante en la vida. El …

Turco, an interventional cardiologist, has held roles including CEO of JC Medical and chief medical officer of Medtronic’s aortic and peripheral vascular business.

Protagonist Therapeutics will now sit back and collect cash from the J&J partnership, including an immediate $50 million payment.

Grade is leaving after a two-year stint defined by changes to Baxter’s business, including the sale of its kidney care unit.

Nearly all physicians said they had already used AI in their practice or are interested in doing so, according to the survey by Doximity. But more than 70% said accuracy and reliability were a top barrier to adoption.